Juniper Pharmaceuticals, Inc. (JNP)
Market Closed
28 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
11. 50
0
0%
$
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
0 Eps
$ 11.5
Previous Close Want to track JNP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Juniper Pharmaceuticals, Inc. (JNP) Statistics
Valuation metrics
Market Cap -
Enterprise value -17.65M
Trailing P/E (ttm) -60.53
Forward P/E -
PEG ratio -0.23
Price/Sales (ttm) -
Price/Book (mrq) 3
Enterprise Value/Revenue -0.35
Enterprise Value/EBITDA 21.18
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 4.3
52-Week high 13.25
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -0.01
Dividend Date -
Ex-Dividend Date -
Last split factor 1:8
Last split Date 9 Aug 2013
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.04%
Operating margin -0.06%
Operational effectiveness
Return on assets -0.03%
Return on equity -0.05%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 4.62
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.19
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.98
Total debt (mrq) -
Total Debt/Equity (mrq) 0.09
Current ratio (mrq) 2.2%
Book value per share (mrq) 3.84
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
